InvestorsHub Logo
Followers 0
Posts 885
Boards Moderated 0
Alias Born 02/15/2016

Re: None

Monday, 02/26/2018 5:28:01 PM

Monday, February 26, 2018 5:28:01 PM

Post# of 1011
looks like everyone is freaking out about a PandL loss.
I usually look at the cash flow statement to see how much cash they are burning through as a more important measurement.
They burned through 3mill last year 2017 and 2.3mill in 2016 which isnt terrible for a pharma play.
They have 8 million in the bank.
Not terribly concerned here.
That number the net cash used in operating activities obviously needs to turn around and fast but they should have revenue starting to come in this year.
thoughts?
these certifications like the they got in europe aint cheap.
the barriers to entry for a legit pharma company in this space are high.